This study is currently not recruiting participants.
A PHASE II EVALUATION OF BELINOSTAT (NSC#726630 IND#729990) AND CARBOPLATIN (NSC #241240) IN THE TREATMENT OF RECURRENT OR PERSISTENT PLATINUM-RESISTANT OVARIAN FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER. GOG 126T
J
Jeanne Schilder, MD
Primary Investigator
Not Recruiting
18 years - 100 years
Female
Phase
N/A
1 Location
Brief description of study
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Age:
18 years - 100 years
Gender: Female
Updated on
01 Aug 2024.
Study ID: 1011003882 (1004-21)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
